Vanguard disaggregates holdings; reports 0 PH shares after realignment (PH)
Rhea-AI Filing Summary
Parker-Hannifin Corp: an amendment to a Schedule 13G/A states that The Vanguard Group reports 0 shares beneficially owned of Parker-Hannifin Common Stock, representing 0% of the class. The filing explains an internal realignment effective 01/12/2026 that caused certain Vanguard subsidiaries and business divisions to report holdings separately; Vanguard states it no longer is deemed to beneficially own securities held by those affiliates. The filing is signed by Ashley Grim on 03/27/2026.
Positive
- None.
Negative
- None.
Insights
Vanguard's disaggregation shifts reporting, showing zero direct ownership here.
The amendment explains an internal reorganization on 01/12/2026 that led certain subsidiaries/divisions to report holdings separately in reliance on SEC Release No. 34-39538. The filing shows 0 shares and 0% ownership attributed to The Vanguard Group in this filing.
Cash-flow treatment and which specific subsidiaries now report these holdings are not detailed; subsequent filings by the disaggregated entities may disclose their positions.
The amendment follows SEC guidance for disaggregated reporting after internal realignment.
The filing cites SEC Release No. 34-39538 and confirms that Vanguard no longer claims beneficial ownership over securities held by certain subsidiaries or business divisions. It is a compliance-driven disclosure rather than a trading or economic-change event.
Investors should note this is a reallocation of reporting responsibility; the filing itself shows 0 shares for The Vanguard Group as of the amendment date 03/27/2026.
FAQ
What does the 13G/A amendment say about Vanguard's holdings in Parker-Hannifin (PH)?
Why did Vanguard report zero shares for Parker-Hannifin in this amendment?
Who signed the Schedule 13G/A amendment for Vanguard and when?
Does this filing identify which Vanguard subsidiaries now report Parker-Hannifin shares?
Does the amendment indicate any trading or change in economic exposure to Parker-Hannifin?